Donation after circulatory death in Turkey and the Middle East: Current status

Q4 Medicine Transplantation Reports Pub Date : 2022-12-01 DOI:10.1016/j.tpr.2022.100109
Mehmet Haberal
{"title":"Donation after circulatory death in Turkey and the Middle East: Current status","authors":"Mehmet Haberal","doi":"10.1016/j.tpr.2022.100109","DOIUrl":null,"url":null,"abstract":"<div><p>Tissue and organ transplantation is the best treatment option for end-stage organ failure. However, organ shortage still remains to be the greatest challenge facing the field of organ transplantation. Millions of people die and are buried with healthy organs, which could save the lives of many patients who continue to wait on transplant lists. Countries must aim to work towards a system of matching organs as much as possible with the deceased donation to meet the growing demand for organs. This action will not only result in the reduction of organ trafficking activities but shall also make an enormous difference to those patients awaiting transplants where living organ donors are not an option.</p><p>Donation after circulator death (DCD) has gained much attention over the last decade as one of the accepted practices in order to expand the donor pool. DCD donation takes place after declaration of death using cardio-respiratory criteria in contrast to donation after brain death (DBD) where neurological criteria are used. Although DCD remains a focus of interest and contributes to donor numbers in many countries, it also poses many challenges medically, ethically and legally. Unfortunately, controlled DCD is not really in practice in Turkey and the Middle East.</p><p>Therefore, the purpose of this review is to provide an overview of current status of DCD in Turkey and the Middle East and to identify associated concerns medically and ethically.</p></div>","PeriodicalId":37786,"journal":{"name":"Transplantation Reports","volume":"7 4","pages":"Article 100109"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2451959622000178/pdfft?md5=236d8870802dfc032c635ed7407de883&pid=1-s2.0-S2451959622000178-main.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2451959622000178","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Tissue and organ transplantation is the best treatment option for end-stage organ failure. However, organ shortage still remains to be the greatest challenge facing the field of organ transplantation. Millions of people die and are buried with healthy organs, which could save the lives of many patients who continue to wait on transplant lists. Countries must aim to work towards a system of matching organs as much as possible with the deceased donation to meet the growing demand for organs. This action will not only result in the reduction of organ trafficking activities but shall also make an enormous difference to those patients awaiting transplants where living organ donors are not an option.

Donation after circulator death (DCD) has gained much attention over the last decade as one of the accepted practices in order to expand the donor pool. DCD donation takes place after declaration of death using cardio-respiratory criteria in contrast to donation after brain death (DBD) where neurological criteria are used. Although DCD remains a focus of interest and contributes to donor numbers in many countries, it also poses many challenges medically, ethically and legally. Unfortunately, controlled DCD is not really in practice in Turkey and the Middle East.

Therefore, the purpose of this review is to provide an overview of current status of DCD in Turkey and the Middle East and to identify associated concerns medically and ethically.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
土耳其和中东地区循环死亡后的捐赠:现状
组织和器官移植是终末期器官衰竭的最佳治疗选择。然而,器官短缺仍然是器官移植领域面临的最大挑战。数百万人死后带着健康的器官下葬,这可以挽救许多继续在移植名单上等待的病人的生命。各国必须致力于建立一个尽可能与死者捐献的器官相匹配的系统,以满足日益增长的器官需求。这一行动不仅将导致器官贩运活动的减少,而且将对那些无法选择活体器官捐赠者的等待移植的患者产生巨大的影响。在过去的十年中,循环者死亡后捐赠(DCD)作为一种公认的做法得到了广泛的关注,以扩大供体池。DCD捐赠是在使用心肺标准宣布死亡后进行的,而脑死亡(DBD)后捐赠则使用神经标准。虽然DCD仍然是许多国家关注的焦点,并有助于增加捐助者数量,但它也带来了许多医学、伦理和法律方面的挑战。不幸的是,在土耳其和中东地区,受控制的DCD并没有真正付诸实践。因此,本次审查的目的是概述土耳其和中东地区DCD的现状,并确定相关的医学和伦理问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Transplantation Reports
Transplantation Reports Medicine-Transplantation
CiteScore
0.60
自引率
0.00%
发文量
24
审稿时长
101 days
期刊介绍: To provide to national and regional audiences experiences unique to them or confirming of broader concepts originating in large controlled trials. All aspects of organ, tissue and cell transplantation clinically and experimentally. Transplantation Reports will provide in-depth representation of emerging preclinical, impactful and clinical experiences. -Original basic or clinical science articles that represent initial limited experiences as preliminary reports. -Clinical trials of therapies previously well documented in large trials but now tested in limited, special, ethnic or clinically unique patient populations. -Case studies that confirm prior reports but have occurred in patients displaying unique clinical characteristics such as ethnicities or rarely associated co-morbidities. Transplantation Reports offers these benefits: -Fast and fair peer review -Rapid, article-based publication -Unrivalled visibility and exposure for your research -Immediate, free and permanent access to your paper on Science Direct -Immediately citable using the article DOI
期刊最新文献
Management challenges in primary hyperoxaluria type 1 with end-stage kidney disease: A case report Report on living liver donor risk and outcomes: Single center experience A national survey of immunosuppression adjustment in elderly lung transplant recipients Combined lung and liver transplant for cirrhosis, idiopathic pulmonary fibrosis, and hemophilia A: Case report Implementing a standardized workflow for early detection of steroid-induced hyperglycemia in allogeneic stem cell transplant recipients: A quality improvement project
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1